You are here : Home / Quarterly Results / GLAXOSMITHKLINE PHARMACEUTICALS LTD

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results Analysis Q2FY22 [Sep2021]

Q-o-Q REVENUES OPERATING PROFIT PROFIT AFTER TAX EPS Updated : 29-Oct-21 Details👇

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Results

Consolidated Sep2021
UnAudited
Jun2021
Audited
Mar2021
UnAudited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
Audited
Mar2020
UnAudited
Dec2019
UnAudited
Revenues ₹1,010 Cr ₹790 Cr ₹814 Cr ₹857 Cr ₹879 Cr ₹649 Cr ₹776 Cr ₹779 Cr
Expenses ₹733 Cr ₹638 Cr ₹643 Cr ₹652 Cr ₹674 Cr ₹535 Cr ₹602 Cr ₹654 Cr
Operating Income ₹277 Cr ₹152 Cr ₹171 Cr ₹206 Cr ₹205 Cr ₹114 Cr ₹174 Cr ₹124 Cr
Other Income ₹15 Cr ₹32 Cr ₹30 Cr ₹14 Cr ₹9 Cr ₹58 Cr ₹16 Cr ₹17 Cr
Interest ₹0 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹1 Cr ₹2 Cr ₹3 Cr
Depreciation ₹18 Cr ₹18 Cr ₹18 Cr ₹18 Cr ₹22 Cr ₹22 Cr ₹23 Cr ₹18 Cr
Profit Before Tax ₹274 Cr ₹165 Cr ₹63 Cr ₹211 Cr ₹127 Cr ₹149 Cr ₹177 Cr ₹-634 Cr
Profit After Tax ₹204 Cr ₹121 Cr ₹14 Cr ₹157 Cr ₹76 Cr ₹111 Cr ₹138 Cr ₹-661 Cr
EPS ₹12.06 ₹7.15 ₹0.85 ₹9.24 ₹4.51 ₹6.54 ₹8.15 ₹-39.03

Check out Industry Peers

Peers & Returns1W1M1Y
GLAXOSMITHKLINE PHARMACEUTICALS -1.9% -2.9% 12%
SUN PHARMACEUTICAL INDUSTRIES -5.4% 1.9% 35.7%
DIVIS LABORATORIES -10.7% -9.1% 14.7%
DR REDDYS LABORATORIES -7% -6% -13.6%
CIPLA -1.2% -1.8% 5.4%
GLAND PHARMA -10.1% -15.1% 56%
PIRAMAL ENTERPRISES -8% -8.2% 58.9%
CADILA HEALTHCARE -6% -12.5% -15.5%
TORRENT PHARMACEUTICALS -2.5% 2% 14.9%

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

27.83 %

Y-o-Y

14.85 %

Quarters Revenues % Change
Sep2021 ₹1,010 Cr
27.83
Jun2021 ₹790 Cr
-2.92
Mar2021 ₹814 Cr
-5.07
Dec2020 ₹857 Cr
-2.52
Sep2020 ₹879 Cr
35.57
Jun2020 ₹649 Cr
-16.40
Mar2020 ₹776 Cr
-0.36
Dec2019 ₹779 Cr -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

82.32 %

Y-o-Y

34.98 %

Quarters Operating Profit % Change
Sep2021 ₹277 Cr
82.32
Jun2021 ₹152 Cr
-11.25
Mar2021 ₹171 Cr
-16.85
Dec2020 ₹206 Cr
0.32
Sep2020 ₹205 Cr
79.59
Jun2020 ₹114 Cr
-34.28
Mar2020 ₹174 Cr
39.53
Dec2019 ₹124 Cr -
Operating Margins
Q-o-Q

42.60 %

Y-o-Y

17.51 %

Quarters Operating Margin% % Change
Sep2021 27.38%
42.60
Jun2021 19.2%
-8.57
Mar2021 21%
-12.39
Dec2020 23.97%
2.88
Sep2020 23.3%
32.46
Jun2020 17.59%
-21.37
Mar2020 22.37%
39.99
Dec2019 15.98% -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

68.68 %

Y-o-Y

167.09 %

Quarters Profit After Tax % Change
Sep2021 ₹204 Cr
68.68
Jun2021 ₹121 Cr
744.94
Mar2021 ₹14 Cr
-90.84
Dec2020 ₹157 Cr
104.67
Sep2020 ₹76 Cr
-31.00
Jun2020 ₹111 Cr
-19.73
Mar2020 ₹138 Cr
Positive
Dec2019 ₹-661 Cr -
PAT Margins
Q-o-Q

31.90 %

Y-o-Y

132.41 %

Quarters PAT Margin(%) % Change
Sep2021 20.22 %
31.90
Jun2021 15.33 %
771.02
Mar2021 1.76 %
-90.36
Dec2020 18.26 %
109.89
Sep2020 8.7 %
-49.09
Jun2020 17.09 %
-3.99
Mar2020 17.8 %
Positive
Dec2019 -84.92 % -

GLAXOSMITHKLINE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

68.67 %

Y-o-Y

167.41 %

Quarters EPS % Change
Sep2021 ₹12.06
68.67
Jun2021 ₹7.15
741.18
Mar2021 ₹0.85
-90.80
Dec2020 ₹9.24
104.88
Sep2020 ₹4.51
-31.04
Jun2020 ₹6.54
-19.75
Mar2020 ₹8.15
Positive
Dec2019 ₹-39.03 -
STOCK RESEARCH & ANALYSIS Smart-Investing
LEARN VIA VIDEO COURSE Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

GLAXOSMITHKLINE PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE LOW VOLATILITY -5% -1% 12.7%
S&P BSE LARGE MIDCAP -6.6% -0.2% 21.9%
S&P BSE 200 -6.6% -0.2% 22.6%
S&P BSE 250 LARGEMIDCAP -6.6% -0.3% 23.3%
S&P BSE 500 -6.8% -0.2% 24.9%
S&P BSE ALLCAP -6.8% -0.1% 26.1%
S&P BSE HEALTHCARE -6.8% -5.1% 10.7%
S&P BSE QUALITY -6.9% -2.3% 12.2%
S&P BSE 150 MIDCAP -7.7% -1.4% 38.3%
S&P BSE 400 MIDSMALLCAP -7.9% -0.7% 42.3%
S&P BSE MIDSMALLCAP -8.1% -1% 43%
S&P BSE MID CAP -8.2% -2.6% 29.6%
NSE Indices1W1M1Y
NIFTY MIDCAP150 QUALITY 50 -3.7% 2.3% NA
NIFTY MNC -5.7% -2.5% 15.2%
NIFTY 500 -6.8% -0.3% 24.9%
NIFTY LARGE MIDCAP 250 -7.1% -1% 28.9%
NIFTY500 MULTICAP 50:25:25 -7.2% -0.3% 33%
NIFTY MIDCAP150 -7.9% -1.9% 37.5%
NIFTY MID SMALL400 -8% -1% 42.6%

You may also like the below Video Courses

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Annual Financials of Industry Peers
Share Price & Financials of SUN PHARMACEUTICAL INDUSTRIES LTD | BOM: 524715 | NSE: SUNPHARMA
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Share Price & Financials of PIRAMAL ENTERPRISES LTD | BOM: 500302 | NSE: PEL
Share Price & Financials of CADILA HEALTHCARE LTD | BOM: 532321 | NSE: CADILAHC
Share Price & Financials of TORRENT PHARMACEUTICALS LTD | BOM: 500420 | NSE: TORNTPHARM
Share Price & Financials of ALKEM LABORATORIES LTD | BOM: 539523 | NSE: ALKEM
Share Price & Financials of LUPIN LTD | BOM: 500257 | NSE: LUPIN
Share Price & Financials of AUROBINDO PHARMA LTD | BOM: 524804 | NSE: AUROPHARMA
Share Price & Financials of BIOCON LTD | BOM: 532523 | NSE: BIOCON
Share Price & Financials of ABBOTT INDIA LTD | BOM: 500488 | NSE: ABBOTINDIA
Share Price & Financials of LAURUS LABS LTD | BOM: 540222 | NSE: LAURUSLABS
Share Price & Financials of IPCA LABORATORIES LTD | BOM: 524494 | NSE: IPCALAB

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z